149 related articles for article (PubMed ID: 20533827)
21. The highest water exchange rate ever measured for a Gd(III) chelate.
Mato-Iglesias M; Platas-Iglesias C; Djanashvili K; Peters JA; Tóth E; Balogh E; Muller RN; Vander Elst L; de Blas A; Rodríguez-Blas T
Chem Commun (Camb); 2005 Oct; (37):4729-31. PubMed ID: 16175307
[TBL] [Abstract][Full Text] [Related]
22. Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations.
Fu Y; Raatschen HJ; Nitecki DE; Wendland MF; Novikov V; Fournier LS; Cyran C; Rogut V; Shames DM; Brasch RC
Biomacromolecules; 2007 May; 8(5):1519-29. PubMed ID: 17402781
[TBL] [Abstract][Full Text] [Related]
23. In vivo evaluation of gadolinium hydroxypyridonate chelates: initial experience as contrast media in magnetic resonance imaging.
Thompson MK; Misselwitz B; Tso LS; Doble DM; Schmitt-Willich H; Raymond KN
J Med Chem; 2005 Jun; 48(11):3874-7. PubMed ID: 15916439
[TBL] [Abstract][Full Text] [Related]
24. A novel cholic acid-based contrast enhancement agent for targeted MRI.
Chong HS; Song HA; Lim S; Macrenaris K; Ma X; Lee H; Bui P; Meade T
Bioorg Med Chem Lett; 2008 Apr; 18(7):2505-8. PubMed ID: 18337094
[TBL] [Abstract][Full Text] [Related]
25. Polyamine-substituted gadolinium chelates: a new class of intracellular contrast agents for magnetic resonance imaging of tumors.
Wolf M; Hull WE; Mier W; Heiland S; Bauder-Wüst U; Kinscherf R; Haberkorn U; Eisenhut M
J Med Chem; 2007 Jan; 50(1):139-48. PubMed ID: 17201417
[TBL] [Abstract][Full Text] [Related]
26. The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model.
Runge VM; Biswas J; Wintersperger BJ; Baumann SS; Jackson CB; Herborn CU; Patel T
Invest Radiol; 2006 Mar; 41(3):244-8. PubMed ID: 16481906
[TBL] [Abstract][Full Text] [Related]
27. Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging.
Silvério S; Torres S; Martins AF; Martins JA; André JP; Helm L; Prata MI; Santos AC; Geraldes CF
Dalton Trans; 2009 Jun; (24):4656-70. PubMed ID: 19513474
[TBL] [Abstract][Full Text] [Related]
28. Separation and characterization of the two diastereomers for [Gd(DTPA-bz-NH2)(H2O)]2-, a common synthon in macromolecular MRI contrast agents: their water exchange and isomerization kinetics.
Burai L; Tóth E; Sour A; Merbach AE
Inorg Chem; 2005 May; 44(10):3561-8. PubMed ID: 15877439
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and characterization of a new bioactivated paramagnetic gadolinium(III) complex [Gd(DOTA-FPG)(H2O)] for tracing gene expression.
Chang YT; Cheng CM; Su YZ; Lee WT; Hsu JS; Liu GC; Cheng TL; Wang YM
Bioconjug Chem; 2007; 18(6):1716-27. PubMed ID: 17935289
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and evaluation of gadolinium complexes based on PAMAM as MRI contrast agents.
Yan GP; Hu B; Liu ML; Li LY
J Pharm Pharmacol; 2005 Mar; 57(3):351-7. PubMed ID: 15807991
[TBL] [Abstract][Full Text] [Related]
31. Gadolinium(III) complexes as MRI contrast agents: ligand design and properties of the complexes.
Hermann P; Kotek J; Kubícek V; Lukes I
Dalton Trans; 2008 Jun; (23):3027-47. PubMed ID: 18521444
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of relaxivity rates of Gd-DTPA complexes by intercalation into layered double hydroxide nanoparticles.
Xu ZP; Kurniawan ND; Bartlett PF; Lu GQ
Chemistry; 2007; 13(10):2824-30. PubMed ID: 17186555
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and characterization of HE-24.8: a polymeric contrast agent for magnetic resonance angiography.
Kiessling F; Heilmann M; Lammers T; Ulbrich K; Subr V; Peschke P; Waengler B; Mier W; Schrenk HH; Bock M; Schad L; Semmler W
Bioconjug Chem; 2006; 17(1):42-51. PubMed ID: 16417250
[TBL] [Abstract][Full Text] [Related]
34. Gd(DO3A-N-alpha-aminopropionate): a versatile and easily available synthon with optimized water exchange for the synthesis of high relaxivity, targeted MRI contrast agents.
Ferreira MF; Martins AF; Martins JA; Ferreira PM; Tóth E; Geraldes CF
Chem Commun (Camb); 2009 Nov; (42):6475-7. PubMed ID: 19841814
[TBL] [Abstract][Full Text] [Related]
35. Physicochemical properties of the high-field MRI-relevant [Gd(DTTA-Me)(H2O)2]- complex.
Moriggi L; Cannizzo C; Prestinari C; Berrière F; Helm L
Inorg Chem; 2008 Sep; 47(18):8357-66. PubMed ID: 18714983
[TBL] [Abstract][Full Text] [Related]
36. The gadolinium(III)-water hydrogen distance in MRI contrast agents.
Caravan P; Astashkin AV; Raitsimring AM
Inorg Chem; 2003 Jun; 42(13):3972-4. PubMed ID: 12817950
[TBL] [Abstract][Full Text] [Related]
37. CNN-Gd(3+) enables cell nucleus molecular imaging of prostate cancer cells: the last 600 nm.
Heckl S; Debus J; Jenne J; Pipkorn R; Waldeck W; Spring H; Rastert R; von der Lieth CW; Braun K
Cancer Res; 2002 Dec; 62(23):7018-24. PubMed ID: 12460922
[TBL] [Abstract][Full Text] [Related]
38. Flow-injection EPR investigation on OH radical scavenging activity of Gd(III) containing MRI contrast media.
Mori Y; Watanabe R; Sakamoto S; Endo N; Nakano S; Kanaori K; Takashima H; Ohkawa M; Tajima K
J Med; 2004; 35(1-6):49-61. PubMed ID: 18084864
[TBL] [Abstract][Full Text] [Related]
39. A chemical strategy for the relaxivity enhancement of Gd(III) chelates anchored on mesoporous silica nanoparticles.
Carniato F; Tei L; Cossi M; Marchese L; Botta M
Chemistry; 2010 Sep; 16(35):10727-34. PubMed ID: 20669190
[TBL] [Abstract][Full Text] [Related]
40. NMR structural studies of the supramolecular adducts between a liver cytosolic bile acid binding protein and gadolinium(III)-chelates bearing bile acids residues: molecular determinants of the binding of a hepatospecific magnetic resonance imaging contrast agent.
Assfalg M; Gianolio E; Zanzoni S; Tomaselli S; Russo VL; Cabella C; Ragona L; Aime S; Molinari H
J Med Chem; 2007 Nov; 50(22):5257-68. PubMed ID: 17915850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
